Financial analysts on Wall Street revised their ratings and price targets on several U.S. listed companies, including Doordash, Phillips 66, and United Therapeutics.
Highlights:
– Doordash: JP Morgan reduces target price to $244 from $272 – Marathon Petroleum Corp: TD Cowen raises target price to $299 from $198 – Packaging Corp of America: JP Morgan lowers target price to $225 from $250 – Phillips 66: TD Cowen increases target price to $213 from $155 – United Therapeutics Corp: Leerink Partners raises target price to $700 from $615
Here is a summary of research actions on U.S. companies reported by Reuters on Thursday, listed alphabetically.
– Alto Neuroscience Inc: Baird reduces target price to $38 from $41 – Bank of America: Goldman Sachs removes from conviction list in the U.S. – Bark Inc: Canaccord Genuity lowers target price to $15 from $30 – Beyond Meat Inc: Jefferies reduces price target to $0.7 from $1.25
And many more companies were included in the revisions.
